Dextranomer
Dextranomer structure
|
Common Name | Dextranomer | ||
|---|---|---|---|---|
| CAS Number | 56087-11-7 | Molecular Weight | 1040.96 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C41H68O30X4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
|
Clinical value of persistent but downgraded vesicoureteral reflux after dextranomer/hyaluronic acid injection in children.
J. Korean Med. Sci. 28(7) , 1060-4, (2013) We aimed to investigate the clinical value of persistent but downgraded vesicoureteral reflux (VUR) after dextranomer/hyaluronic acid (Dx/HA) injection in children. The medical records of 128 children (195 ureters) who underwent Dx/HA injections for VUR were ... |
|
|
Dextranomer/hyaluronic injection for the management of vesicoureteric reflux in complete ureteral duplication: should age and gender be factors in decision making?
J. Endourol. 24(6) , 1013-6, (2010) The injection of dextranomer/hyaluronic acid (DHA) has become an accepted treatment for children with vesicoureteral reflux (VUR). Complete ureteral duplication has been considered by some practitioners as counterindication for its use. We reviewed the Texas ... |
|
|
Endoscopic treatment of vesicoureteral reflux using dextranomer/hyaluronic acid copolymer in children: results of postoperative follow-up with real-time 3D sonography.
Urol. Int. 87(2) , 192-8, (2011) We evaluated whether real-time 3D ultrasound (4D-US) together with clinical evaluation is an alternative to voiding cystourethrography (VCUG) after endoscopic treatment of vesicoureteral reflux (VUR) in children at postoperative follow-up.We reviewed 178 chil... |
|
|
Debridement for surgical wounds.
Cochrane Database Syst. Rev. 9 , CD006214, (2013) Surgical wounds that become infected are often debrided because clinicians believe that removal of this necrotic or infected tissue will expedite wound healing. There are numerous methods available but no consensus on which one is most effective for surgical ... |
|
|
Editorial comment.
J. Urol. 188(1) , 261, (2012)
|
|
|
Injection therapy for reflux: why it works and why it fails.
J. Urol. 188(1) , 16-7, (2012)
|
|
|
Response to commentary by P.H. Noh
J. Pediatr. Urol. 8(4) , 448, (2012)
|
|
|
Commentary to "Intermediate-long term follow-up indicates low risk of recurrence after double HIT endoscopic treatment for primary vesicoureteral reflux (VUR)".
J. Pediatr. Urol. 8(4) , 366, (2012)
|
|
|
Intermediate to long-term follow-up indicates low risk of recurrence after double HIT endoscopic treatment for primary vesico-ureteral reflux
J. Pediatr. Urol. 8(4) , 449, (2012)
|
|
|
Commentary to ‘Clinical and radiographic results of endoscopic injection for vesicoureteral reflux: Defining measures of success’
J. Pediatr. Urol. 8(3) , 304-5; discussion 306, (2012)
|